• Nenhum resultado encontrado

Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.

N/A
N/A
Protected

Academic year: 2017

Share "Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto."

Copied!
16
0
0

Texto

Loading

Imagem

Table 1. Demographic characteristics among MSM living with and without HIV in Toronto.
Table 2. Prevalence of bacterial and viral pathogens among MSM living with and without HIV in Toronto * .
Table 3. Correlates of hepatitis B virus infection among MSM in Toronto.
Table 4 summarizes the results of the analysis of the covariates of HCV infection among MSM living with HIV
+3

Referências

Documentos relacionados

E no que diz respeito à facilidade de encontrar no mercado de trabalho, trabalhadores com perfil adequado para a área de alojamento, o entrevistado explica que é mais fácil

The CRF01_AE sequences isolated in MSM in China formed two clusters and the highest rates of evolution were observed in the env gene.. In addition, the amino acids mutations at

information were collected by trained interviewers through a questionnaire based survey. A similar follow-up questionnaire was completed at each subsequent visit... The

Social and sexual networks may influence HIV risk.[ 9 – 14 ] HIV prevalence in a sexual net- work, and the position of an individual within that network, may have as much effect on

O objectivo principal deste trabalho é fazer um diagnóstico do tipo de informação ambiental e social divulgada pelas empresas nos seus relatórios públicos, quais as

The HIV infection prevalence rate was 0.09%, in 2002, which remained unchanged since1998 Riskier sexual practices among young men with incomplete education and among “men who have

We assessed occult HBV infection prevalence in two groups of immunocompromised patients (maintenance hemodialysis patients and HIV-positive patients) presenting HBsAg- negative

Evolução da produção hospitalar relativa a Neoplasia Maligna do Colo Útero, Portugal Continental (2010 a 2014) 18 Figura 19. Evolução da produção